Post-approval studies (Phase 4)Ended earlyNCT00972543What this trial is testingRaptiva in Palm and Sole PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 6
Post-approval studies (Phase 4)Study completedNCT00493324What this trial is testingStudy to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Astellas Pharma Inc 43
Post-approval studies (Phase 4)Study completedNCT00932113What this trial is testingMechanism of Action Study for PsoriasisWho this might be right forPsoriasis Tufts Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00770965What this trial is testingPhase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT03131570What this trial is testingSafety and Efficacy of Secukinumab in Mild PsoriasisWho this might be right forPsoriasis James G. Krueger, MD, PhD 23
Not applicableStudy completedNCT00678470What this trial is testingOpen Label Study of Alefacept Injections to Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis University of California, San Francisco 18
Not applicableWithdrawnNCT01758705What this trial is testingPost Marketing Observational Study on Venezuelan Patients With PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbbVie (prior sponsor, Abbott)
Large-scale testing (Phase 3)Study completedNCT02074982What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisWho this might be right forChronic Plaque Type Psoriasis Novartis Pharmaceuticals 676
Large-scale testing (Phase 3)Study completedNCT00408187What this trial is testingRandomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsWho this might be right forPsoriasis Aurinia Pharmaceuticals Inc. 642
Testing effectiveness (Phase 2)Study completedNCT02905006What this trial is testingStudy to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT00679731What this trial is testingSafety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie (prior sponsor, Abbott) 317
Post-approval studies (Phase 4)UnknownNCT05555797What this trial is testingExcimer Laser With Topical Agents in Psoriasis VulgarisWho this might be right forPsoriasis Assiut University 30
Large-scale testing (Phase 3)Study completedNCT02016482What this trial is testingEvaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail PsoriasisWho this might be right forNail PsoriasisPlaque Psoriasis AbbVie 217
Large-scale testing (Phase 3)Study completedNCT03066609What this trial is testingStudy of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 543
Large-scale testing (Phase 3)Study completedNCT04930042What this trial is testingEfficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Alvotech Swiss AG 581
Large-scale testing (Phase 3)Study completedNCT00570986What this trial is testingA Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis AbbVie (prior sponsor, Abbott) 1,465
Testing effectiveness (Phase 2)Study completedNCT01914627What this trial is testingParallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis CapitisWho this might be right forScalp Psoriasis G. Pohl-Boskamp GmbH & Co. KG 90
Large-scale testing (Phase 3)Study completedNCT00254982What this trial is testingInfliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)Who this might be right forPsoriasis Merck Sharp & Dohme LLC 593
Large-scale testing (Phase 3)Study completedNCT00674063What this trial is testingAssess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Astellas Pharma Inc 78
Early research (Phase 1)Study completedNCT01836939What this trial is testingSafety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Mark Lebwohl 8